Literature DB >> 12536351

Venous thromboembolic risk and its prevention in hospitalized medical patients.

Sylvia K Haas1.   

Abstract

In medical patients, the risk of venous thromboembolism (VTE) is substantially underestimated and prophylaxis is used far less than in surgical patients, reflecting the scarcity of evidence supporting antithrombotic therapy in nonsurgical settings. However, current consensus documents recommend assessment of all medical, as well as surgical, patients for thromboembolic risk and provide prophylaxis recommendations according to the risk level, determined by the presence of different clinical and molecular risk factors. Although long-term, underlying clinical and molecular risk factors also have a major impact on overall risk in medical patients; risk clearly varies with the type of medical condition. Myocardial infarction, stroke, and malignant disease are linked to a high rate of VTE; recent evidence highlights patients with cardiopulmonary disease as a distinct risk group. Despite skepticism in some quarters, high-quality evidence confirms the efficacy of unfractionated heparin (UFH) and low-molecular-weight heparins (LMWH) in reducing asymptomatic deep vein thrombosis (DVT) in a broad spectrum of medical patients; further studies are required to clarify the effect on fatal pulmonary embolism (PE). Emerging data from the recent PRINCE and MEDENOX studies demonstrate that the LMWH enoxaparin provides effective and well-tolerated VTE prevention in patients with severe cardiopulmonary disease. Emerging evidence has led to a grade 1A recommendation for the use of thromboprophylaxis in these patients in the most recent consensus conference on thromboprophylaxis. Further studies, however, are required to clarify the optimal duration of prophylaxis in medical patients and to evaluate the potential role of outpatient prophylaxis. Accurate risk assessment and prompt implementation of appropriate prophylaxis, selected on the basis of evidence from well-designed controlled clinical trials, may reduce the future morbidity and mortality due to VTE in medical patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12536351     DOI: 10.1055/s-2002-36702

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  10 in total

1.  Risk factors of acute pulmonary thromboembolism in Japanese patients hospitalized for medical illness: results of a multicenter registry in the Japanese society of pulmonary embolism research.

Authors:  Mashio Nakamura; Masahito Sakuma; Norikazu Yamada; Nobuhiro Tanabe; Norifumi Nakanishi; Yoshiyuki Miyahara; Takayuki Kuriyama; Takeyoshi Kunieda; Kunio Shirato; Tsuneaki Sugimoto; Takeshi Nakano
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

Review 2.  Permanent versus Retrievable Inferior Vena Cava Filters: Rethinking the "One-Filter-for-All" Approach to Mechanical Thromboembolic Prophylaxis.

Authors:  Christine E Ghatan; Robert K Ryu
Journal:  Semin Intervent Radiol       Date:  2016-06       Impact factor: 1.513

Review 3.  Prevention of venous thromboembolism in medically ill patients: a clinical update.

Authors:  Alexander G G Turpie; Alain Leizorovicz
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

Review 4.  Standard or extended-duration prophylaxis in medical patients? A review of the evidence.

Authors:  J E Stark; W J Smith
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

Review 5.  Optional vena cava filters: indications, management, and results.

Authors:  Hanno Hoppe
Journal:  Dtsch Arztebl Int       Date:  2009-06-12       Impact factor: 5.594

6.  Underutilization of venous thromboemoblism prophylaxis in medical patients in a tertiary care center.

Authors:  Ramy Masroujeh; Wael Shamseddeen; Hussain Isma'eel; Zaher K Otrock; Ismail M Khalil; Ali Taher
Journal:  J Thromb Thrombolysis       Date:  2007-08-15       Impact factor: 2.300

7.  An evaluation of practice pattern for venous thromboembolism prevention in Lebanese hospitals.

Authors:  Abeer A Zeitoun; Hani I Dimassi; Dania Y El Kary; Marwan G Akel
Journal:  J Thromb Thrombolysis       Date:  2008-12-27       Impact factor: 2.300

8.  Adherence to local guidelines for venous thromboprophylaxis: a cross-sectional study of medical inpatients in Argentina.

Authors:  Agustín Languasco; Mariana Galante; Josefina Marín; Cristina Soler; Cristián Lopez Saubidet; Matías Milberg
Journal:  Thromb J       Date:  2011-12-15

9.  An update on prevention of venous thromboembolism in hospitalized acutely ill medical patients.

Authors:  Meyer Michel Samama; Franz-Xaver Kleber
Journal:  Thromb J       Date:  2006-07-03

10.  Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts.

Authors:  Greg Maynard; Jason Stein
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.